» Articles » PMID: 28426185

Integrated HIV Care and Service Engagement Among People Living with HIV Who Use Drugs in a Setting with a Community-wide Treatment As Prevention Initiative: a Qualitative Study in Vancouver, Canada

Overview
Journal J Int AIDS Soc
Date 2017 Apr 21
PMID 28426185
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Social-structural inequities impede access to, and retention in, HIV care among structurally vulnerable people living with HIV (PLHIV) who use drugs. The resulting disparities in HIV-related outcomes among PLHIV who use drugs pose barriers to the optimization of HIV treatment as prevention (TasP) initiatives. We undertook this study to examine engagement with, and impacts of, an integrated HIV care services model tailored to the needs of PLHIV who use drugs in Vancouver, Canada - a setting with a community-wide TasP initiative.

Methods: We conducted qualitative interviews with 30 PLHIV who use drugs recruited from the Dr. Peter Centre, an HIV care facility operating under an integrated services model and harm reduction approach. We employed novel analytical techniques to analyse participants' service trajectories within this facility to understand how this HIV service environment influences access to, and retention in, HIV care among structurally vulnerable PLHIV who use drugs.

Results: Our findings demonstrate that participants' structural vulnerability shaped their engagement with the HIV care facility that provided access to resources that facilitated retention in HIV care and antiretroviral treatment adherence. Additionally, the integrated service environment helped reduce burdens associated with living in extreme poverty by meeting participants' subsistence (e.g. food, shelter) needs. Moreover, access to multiple supports created a structured environment in which participants could develop routine service use patterns and have prolonged engagement with supportive care services. Our findings demonstrate that low-barrier service models can mitigate social and structural barriers to HIV care and complement TasP initiatives for PLHIV who use drugs.

Conclusion: These findings highlight the critical role of integrated service models in promoting access to health and support services for structurally vulnerable PLHIV. Complementing structural interventions with integrated service models that are tailored to the needs of structurally vulnerable PLHIV who use drugs will be pursuant to the goals of TasP.

Citing Articles

"Everybody looks at it as drug use instead of pain management": Experiences of chronic pain and its management among older people living with HIV who use drugs in Vancouver, British Columbia.

Chayama K, Ng C, Ivsins A, Small W, Knight R, McNeil R Drug Alcohol Depend. 2024; 262:111399.

PMID: 39029372 PMC: 11444243. DOI: 10.1016/j.drugalcdep.2024.111399.


"It feels like I'm coming to a friend's house": an interpretive descriptive study of an integrated care site offering iOAT (Dr. Peter Centre).

Dobischok S, Carvajal J, Turner K, Jaffe K, Lehal E, Blawatt S Addict Sci Clin Pract. 2023; 18(1):73.

PMID: 38042844 PMC: 10693115. DOI: 10.1186/s13722-023-00428-4.


Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island.

Collins A, Macon E, Langdon K, Joseph R, Thomas A, Dogon C J Urban Health. 2023; 100(5):1062-1073.

PMID: 37563518 PMC: 10618145. DOI: 10.1007/s11524-023-00755-6.


Supporting intersecting cultural needs of gender and age by increasing cultural safety and humility for Housing First initiatives.

Fang M, Canham S, Battersby L BMC Public Health. 2023; 23(1):1005.

PMID: 37254119 PMC: 10227820. DOI: 10.1186/s12889-023-15955-7.


Exploring current nutritional programming and resources available to people living with HIV in Canada: a scoping review.

Mannette J, Zhang Y, Rothfus M, Purdy C, Tesfatsion W, Lynch M JBI Evid Synth. 2023; 21(10):2022-2081.

PMID: 37194312 PMC: 10566589. DOI: 10.11124/JBIES-22-00168.


References
1.
Milloy M, Montaner J, Wood E . Barriers to HIV treatment among people who use injection drugs: implications for 'treatment as prevention'. Curr Opin HIV AIDS. 2012; 7(4):332-8. DOI: 10.1097/COH.0b013e328354bcc8. View

2.
Krusi A, Small W, Wood E, Kerr T . An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care. 2009; 21(5):638-44. DOI: 10.1080/09540120802385645. View

3.
Anema A, Chan K, Chen Y, Weiser S, Montaner J, Hogg R . Relationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, Canada. PLoS One. 2013; 8(5):e61277. PMC: 3664561. DOI: 10.1371/journal.pone.0061277. View

4.
McNeil R, Kerr T, Coleman B, Maher L, Milloy M, Small W . Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative. AIDS Behav. 2016; 21(2):402-409. PMC: 5360157. DOI: 10.1007/s10461-016-1470-2. View

5.
Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J . Public health and international drug policy. Lancet. 2016; 387(10026):1427-1480. PMC: 5042332. DOI: 10.1016/S0140-6736(16)00619-X. View